Small pulmonary nodules in baseline and incidence screening rounds of low-dose CT lung cancer screening.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28331823)

Published in Transl Lung Cancer Res on February 01, 2017

Authors

Joan E Walter1, Marjolein A Heuvelmans1, Matthijs Oudkerk1

Author Affiliations

1: University Medical Center Groningen, Center for Medical Imaging-North East Netherlands, Groningen, The Netherlands.

Articles cited by this

Global cancer statistics. CA Cancer J Clin (2011) 185.92

Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med (2011) 38.61

Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med (2006) 19.06

Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet (1999) 13.67

Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology (2005) 9.83

Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71

Management of lung nodules detected by volume CT scanning. N Engl J Med (2009) 6.79

The National Lung Screening Trial: overview and study design. Radiology (2010) 6.43

Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 6.26

Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med (2013) 5.92

Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med (2002) 5.10

Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.83

The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg (2012) 4.68

CT screening for lung cancer: five-year prospective experience. Radiology (2005) 4.33

The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med (2008) 4.22

Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med (2013) 3.47

Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. Ann Intern Med (2012) 3.45

The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer (2007) 3.15

Concern Early lung cancer action project: initial findings on repeat screenings. Cancer (2001) 2.99

Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer (2007) 2.85

CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax (2012) 2.81

Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol (2014) 2.78

Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.77

Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med (2013) 2.66

The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round. J Thorac Oncol (2009) 2.48

Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg (1988) 2.09

British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax (2015) 2.05

Survival in early-stage non-small cell lung cancer. Ann Thorac Surg (1995) 2.01

Lung cancer screening. J Natl Compr Canc Netw (2012) 2.00

Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin (2015) 1.97

Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer (2006) 1.89

Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer (2008) 1.68

Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer (2007) 1.37

Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol (2012) 1.15

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax (2015) 1.08

European randomized lung cancer screening trials: Post NLST. J Surg Oncol (2013) 1.08

Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. Lung Cancer (2007) 1.06

Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials. J Thorac Oncol (2010) 1.03

Can lung cancer screening by computed tomography be effective in areas with endemic histoplasmosis? J Thorac Cardiovasc Surg (2010) 0.95

Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol (2016) 0.95

Screening for lung cancer: the US studies. J Surg Oncol (2013) 0.84

Lung cancer risk in new pulmonary nodules: implications for CT screening and nodule management. Lancet Oncol (2016) 0.83

A meta-analysis: is low-dose computed tomography a superior method for risky lung cancers screening population? Clin Respir J (2014) 0.78

Low-dose computed tomography screening for lung cancer in populations highly exposed to tobacco: A systematic methodological appraisal of published randomised controlled trials. Eur J Cancer (2016) 0.78